{"entity":{"type":"insider","cik":"0001672659","url":"/insider/0001672659","json_url":"/insider/0001672659.json","name":"Rodman David Malcom","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":60,"n_filings":37,"first":"2016-07-06","last":"2026-08-12","span_basis":"filed_date"},"name_variants":[{"name":"Rodman David Malcom","source":"filing","n_filings":37,"first_seen":"2016-07-06","last_seen":"2026-08-12"}],"transactions":[{"id":9296754,"accession":"0001933414-26-000118","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-26-000118","line_url":"/filing/0001933414-26-000118#line-1","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2170.0,"shares_display":"2,170","price_per_share":27.09,"price_display":"27.09","price_state":"stated","total_value":58785.3,"total_display":"58,785.30","total_whole":"58,785","shares_owned_after":51384.0,"shares_owned_after_display":"51,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-12","scope":"insider"},{"id":6174616,"accession":"0001672659-26-000036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001672659-26-000036","line_url":"/filing/0001672659-26-000036#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":416.0,"shares_display":"416","price_per_share":26.53,"price_display":"26.53","price_state":"stated","total_value":11036.48,"total_display":"11,036.48","total_whole":"11,036","shares_owned_after":51384.0,"shares_owned_after_display":"51,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-17","filed_date":"2026-07-20","scope":"insider"},{"id":6066590,"accession":"0001933414-26-000099","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001933414-26-000099","line_url":"/filing/0001933414-26-000099#line-5","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6349.0,"shares_display":"6,349","price_per_share":26.6112,"price_display":"26.61","price_state":"stated","total_value":168954.5088,"total_display":"168,954.51","total_whole":"168,955","shares_owned_after":51384.0,"shares_owned_after_display":"51,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-15","filed_date":"2026-07-15","scope":"insider"},{"id":6066588,"accession":"0001933414-26-000099","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001933414-26-000099","line_url":"/filing/0001933414-26-000099#line-4","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14058.0,"shares_display":"14,058","price_per_share":27.5798,"price_display":"27.58","price_state":"stated","total_value":387716.8284,"total_display":"387,716.83","total_whole":"387,717","shares_owned_after":57733.0,"shares_owned_after_display":"57,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-13","filed_date":"2026-07-15","scope":"insider"},{"id":5968000,"accession":"0001672659-26-000033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001672659-26-000033","line_url":"/filing/0001672659-26-000033#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2171.0,"shares_display":"2,171","price_per_share":30.3,"price_display":"30.30","price_state":"stated","total_value":65781.3,"total_display":"65,781.30","total_whole":"65,781","shares_owned_after":57733.0,"shares_owned_after_display":"57,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-09","filed_date":"2026-07-10","scope":"insider"},{"id":6066580,"accession":"0001933414-26-000094","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001933414-26-000094","line_url":"/filing/0001933414-26-000094#line-5","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4584.0,"shares_display":"4,584","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":114600.0,"total_display":"114,600.00","total_whole":"114,600","shares_owned_after":57095.0,"shares_owned_after_display":"57,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-17","filed_date":"2026-06-17","scope":"insider"},{"id":6066572,"accession":"0001933414-26-000094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001933414-26-000094","line_url":"/filing/0001933414-26-000094#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9890.0,"shares_display":"9,890","price_per_share":23.8106,"price_display":"23.81","price_state":"stated","total_value":235486.834,"total_display":"235,486.83","total_whole":"235,487","shares_owned_after":57095.0,"shares_owned_after_display":"57,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-17","scope":"insider"},{"id":6060350,"accession":"0001672659-26-000030","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001672659-26-000030","line_url":"/filing/0001672659-26-000030#line-4","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6349.0,"shares_display":"6,349","price_per_share":23.9252,"price_display":"23.93","price_state":"stated","total_value":151901.0948,"total_display":"151,901.09","total_whole":"151,901","shares_owned_after":63443.0,"shares_owned_after_display":"63,443","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-12","filed_date":"2026-06-12","scope":"insider"},{"id":6060345,"accession":"0001672659-26-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001672659-26-000030","line_url":"/filing/0001672659-26-000030#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2170.0,"shares_display":"2,170","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":54250.0,"total_display":"54,250.00","total_whole":"54,250","shares_owned_after":63443.0,"shares_owned_after_display":"63,443","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-10","filed_date":"2026-06-12","scope":"insider"},{"id":6066566,"accession":"0001933414-26-000086","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001933414-26-000086","line_url":"/filing/0001933414-26-000086#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":27.55,"price_display":"27.55","price_state":"stated","total_value":11488.35,"total_display":"11,488.35","total_whole":"11,488","shares_owned_after":63443.0,"shares_owned_after_display":"63,443","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-19","scope":"insider"},{"id":5778702,"accession":"0001672659-26-000027","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001672659-26-000027","line_url":"/filing/0001672659-26-000027#line-7","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14056.0,"shares_display":"14,056","price_per_share":28.5849,"price_display":"28.58","price_state":"stated","total_value":401789.3544,"total_display":"401,789.35","total_whole":"401,789","shares_owned_after":63443.0,"shares_owned_after_display":"63,443","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-13","filed_date":"2026-05-13","scope":"insider"},{"id":5778699,"accession":"0001672659-26-000027","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001672659-26-000027","line_url":"/filing/0001672659-26-000027#line-4","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6348.0,"shares_display":"6,348","price_per_share":29.3554,"price_display":"29.36","price_state":"stated","total_value":186348.0792,"total_display":"186,348.08","total_whole":"186,348","shares_owned_after":69792.0,"shares_owned_after_display":"69,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-12","filed_date":"2026-05-13","scope":"insider"},{"id":5778697,"accession":"0001672659-26-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001672659-26-000027","line_url":"/filing/0001672659-26-000027#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2171.0,"shares_display":"2,171","price_per_share":29.71,"price_display":"29.71","price_state":"stated","total_value":64500.41,"total_display":"64,500.41","total_whole":"64,500","shares_owned_after":69792.0,"shares_owned_after_display":"69,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-13","scope":"insider"},{"id":6060339,"accession":"0001672659-26-000024","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001672659-26-000024","line_url":"/filing/0001672659-26-000024#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":416.0,"shares_display":"416","price_per_share":31.33,"price_display":"31.33","price_state":"stated","total_value":13033.28,"total_display":"13,033.28","total_whole":"13,033","shares_owned_after":69792.0,"shares_owned_after_display":"69,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-17","filed_date":"2026-04-21","scope":"insider"},{"id":5912734,"accession":"0001933414-26-000076","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001933414-26-000076","line_url":"/filing/0001933414-26-000076#line-5","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6348.0,"shares_display":"6,348","price_per_share":27.66,"price_display":"27.66","price_state":"stated","total_value":175585.68,"total_display":"175,585.68","total_whole":"175,586","shares_owned_after":69792.0,"shares_owned_after_display":"69,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-15","scope":"insider"},{"id":5912732,"accession":"0001933414-26-000076","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001933414-26-000076","line_url":"/filing/0001933414-26-000076#line-4","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14058.0,"shares_display":"14,058","price_per_share":26.5391,"price_display":"26.54","price_state":"stated","total_value":373086.6678,"total_display":"373,086.67","total_whole":"373,087","shares_owned_after":76140.0,"shares_owned_after_display":"76,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-13","filed_date":"2026-04-15","scope":"insider"},{"id":5885356,"accession":"0001672659-26-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001672659-26-000020","line_url":"/filing/0001672659-26-000020#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2170.0,"shares_display":"2,170","price_per_share":27.38,"price_display":"27.38","price_state":"stated","total_value":59414.6,"total_display":"59,414.60","total_whole":"59,415","shares_owned_after":76140.0,"shares_owned_after_display":"76,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-09","filed_date":"2026-04-13","scope":"insider"},{"id":5987625,"accession":"0001672659-26-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001672659-26-000018","line_url":"/filing/0001672659-26-000018#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":25.65,"price_display":"25.65","price_state":"stated","total_value":10696.05,"total_display":"10,696.05","total_whole":"10,696","shares_owned_after":76140.0,"shares_owned_after_display":"76,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-17","scope":"insider"},{"id":6083322,"accession":"0001933414-26-000058","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001933414-26-000058","line_url":"/filing/0001933414-26-000058","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14058.0,"shares_display":"14,058","price_per_share":26.26443669796557,"price_display":"26.26","price_state":"stated","total_value":369225.4511,"total_display":"369,225.45","total_whole":"369,225","shares_owned_after":79472.0,"shares_owned_after_display":"79,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-13","filed_date":"2026-03-16","scope":"insider","n_lines":3},{"id":6083312,"accession":"0001933414-26-000058","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001933414-26-000058","line_url":"/filing/0001933414-26-000058#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6348.0,"shares_display":"6,348","price_per_share":27.3705,"price_display":"27.37","price_state":"stated","total_value":173747.934,"total_display":"173,747.93","total_whole":"173,748","shares_owned_after":82489.0,"shares_owned_after_display":"82,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-12","filed_date":"2026-03-16","scope":"insider"},{"id":5828178,"accession":"0001672659-26-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001672659-26-000015","line_url":"/filing/0001672659-26-000015#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2171.0,"shares_display":"2,171","price_per_share":26.84,"price_display":"26.84","price_state":"stated","total_value":58269.64,"total_display":"58,269.64","total_whole":"58,270","shares_owned_after":82489.0,"shares_owned_after_display":"82,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-09","filed_date":"2026-03-10","scope":"insider"},{"id":5815214,"accession":"0001672659-26-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001672659-26-000013","line_url":"/filing/0001672659-26-000013#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":27.59,"price_display":"27.59","price_state":"stated","total_value":11505.03,"total_display":"11,505.03","total_whole":"11,505","shares_owned_after":44089.0,"shares_owned_after_display":"44,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-17","scope":"insider"},{"id":6198301,"accession":"0001672659-26-000011","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001672659-26-000011","line_url":"/filing/0001672659-26-000011","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14055.0,"shares_display":"14,055","price_per_share":27.444494343649946,"price_display":"27.44","price_state":"stated","total_value":385732.368,"total_display":"385,732.37","total_whole":"385,732","shares_owned_after":44089.0,"shares_owned_after_display":"44,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-13","scope":"insider","n_lines":3},{"id":6198285,"accession":"0001672659-26-000011","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001672659-26-000011","line_url":"/filing/0001672659-26-000011","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6349.0,"shares_display":"6,349","price_per_share":28.993021121436445,"price_display":"28.99","price_state":"stated","total_value":184076.6911,"total_display":"184,076.69","total_whole":"184,077","shares_owned_after":50958.0,"shares_owned_after_display":"50,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-12","filed_date":"2026-02-13","scope":"insider","n_lines":2},{"id":5819753,"accession":"0001933414-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001933414-26-000007","line_url":"/filing/0001933414-26-000007#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2171.0,"shares_display":"2,171","price_per_share":30.21,"price_display":"30.21","price_state":"stated","total_value":65585.91,"total_display":"65,585.91","total_whole":"65,586","shares_owned_after":50437.0,"shares_owned_after_display":"50,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-09","filed_date":"2026-02-11","scope":"insider"},{"id":5746657,"accession":"0001672659-26-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001672659-26-000008","line_url":"/filing/0001672659-26-000008#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":416.0,"shares_display":"416","price_per_share":32.1,"price_display":"32.10","price_state":"stated","total_value":13353.6,"total_display":"13,353.60","total_whole":"13,354","shares_owned_after":50437.0,"shares_owned_after_display":"50,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-20","scope":"insider"},{"id":5778695,"accession":"0001672659-26-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001672659-26-000006","line_url":"/filing/0001672659-26-000006#line-4","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11367.0,"shares_display":"11,367","price_per_share":32.6071,"price_display":"32.61","price_state":"stated","total_value":370644.9057,"total_display":"370,644.91","total_whole":"370,645","shares_owned_after":50437.0,"shares_owned_after_display":"50,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-14","filed_date":"2026-01-15","scope":"insider"},{"id":5778694,"accession":"0001672659-26-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001672659-26-000006","line_url":"/filing/0001672659-26-000006#line-3","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7709.0,"shares_display":"7,709","price_per_share":32.75,"price_display":"32.75","price_state":"stated","total_value":252469.75,"total_display":"252,469.75","total_whole":"252,470","shares_owned_after":61804.0,"shares_owned_after_display":"61,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-15","scope":"insider"},{"id":5757928,"accession":"0001672659-26-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001672659-26-000004","line_url":"/filing/0001672659-26-000004#line-4","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6348.0,"shares_display":"6,348","price_per_share":32.3162,"price_display":"32.32","price_state":"stated","total_value":205143.2376,"total_display":"205,143.24","total_whole":"205,143","shares_owned_after":61804.0,"shares_owned_after_display":"61,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-13","scope":"insider"},{"id":5757925,"accession":"0001672659-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001672659-26-000004","line_url":"/filing/0001672659-26-000004#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2170.0,"shares_display":"2,170","price_per_share":33.27,"price_display":"33.27","price_state":"stated","total_value":72195.9,"total_display":"72,195.90","total_whole":"72,196","shares_owned_after":61804.0,"shares_owned_after_display":"61,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-09","filed_date":"2026-01-13","scope":"insider"},{"id":5875512,"accession":"0001672659-26-000002","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001672659-26-000002","line_url":"/filing/0001672659-26-000002","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":192715.0,"shares_display":"192,715","price_per_share":35.0211922761591,"price_display":"35.02","price_state":"stated","total_value":6749109.0695,"total_display":"6,749,109.07","total_whole":"6,749,109","shares_owned_after":115274.0,"shares_owned_after_display":"115,274","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-06","scope":"insider","n_lines":2},{"id":5875498,"accession":"0001672659-26-000002","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001672659-26-000002","line_url":"/filing/0001672659-26-000002#line-6","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70037.0,"shares_display":"70,037","price_per_share":35.8656,"price_display":"35.87","price_state":"stated","total_value":2511919.0272,"total_display":"2,511,919.03","total_whole":"2,511,919","shares_owned_after":69188.0,"shares_owned_after_display":"69,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-06","scope":"insider"},{"id":4857585,"accession":"0001933414-25-000128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-25-000128","line_url":"/filing/0001933414-25-000128#line-1","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10369.0,"shares_display":"10,369","price_per_share":43.0111,"price_display":"43.01","price_state":"stated","total_value":445982.0959,"total_display":"445,982.10","total_whole":"445,982","shares_owned_after":71155.0,"shares_owned_after_display":"71,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-15","filed_date":"2025-10-15","scope":"insider"},{"id":4438008,"accession":"0001672659-25-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001672659-25-000006","line_url":"/filing/0001672659-25-000006","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11367.0,"shares_display":"11,367","price_per_share":36.00474908067212,"price_display":"36.00","price_state":"stated","total_value":409265.9828,"total_display":"409,265.98","total_whole":"409,266","shares_owned_after":83589.0,"shares_owned_after_display":"83,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-15","filed_date":"2025-09-16","scope":"insider","n_lines":2},{"id":4826919,"accession":"0001933414-25-000093","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001933414-25-000093","line_url":"/filing/0001933414-25-000093#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11365.0,"shares_display":"11,365","price_per_share":12.9333,"price_display":"12.93","price_state":"stated","total_value":146986.9545,"total_display":"146,986.95","total_whole":"146,987","shares_owned_after":92891.0,"shares_owned_after_display":"92,891","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-13","filed_date":"2025-08-14","scope":"insider"},{"id":5180494,"accession":"0001933414-25-000076","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001933414-25-000076","line_url":"/filing/0001933414-25-000076#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11366.0,"shares_display":"11,366","price_per_share":14.5943,"price_display":"14.59","price_state":"stated","total_value":165878.8138,"total_display":"165,878.81","total_whole":"165,879","shares_owned_after":97907.0,"shares_owned_after_display":"97,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-14","filed_date":"2025-07-15","scope":"insider"},{"id":4562929,"accession":"0001933414-25-000067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001933414-25-000067","line_url":"/filing/0001933414-25-000067#line-2","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11366.0,"shares_display":"11,366","price_per_share":14.5989,"price_display":"14.60","price_state":"stated","total_value":165931.0974,"total_display":"165,931.10","total_whole":"165,931","shares_owned_after":101651.0,"shares_owned_after_display":"101,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-13","filed_date":"2025-06-16","scope":"insider"},{"id":4285870,"accession":"0001933414-25-000062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-25-000062","line_url":"/filing/0001933414-25-000062#line-1","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11366.0,"shares_display":"11,366","price_per_share":15.2889,"price_display":"15.29","price_state":"stated","total_value":173773.6374,"total_display":"173,773.64","total_whole":"173,774","shares_owned_after":106669.0,"shares_owned_after_display":"106,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-14","filed_date":"2025-05-15","scope":"insider"},{"id":5222044,"accession":"0001933414-25-000047","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001933414-25-000047","line_url":"/filing/0001933414-25-000047","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11366.0,"shares_display":"11,366","price_per_share":14.533269523139188,"price_display":"14.53","price_state":"stated","total_value":165185.1414,"total_display":"165,185.14","total_whole":"165,185","shares_owned_after":111686.0,"shares_owned_after_display":"111,686","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-14","filed_date":"2025-04-15","scope":"insider","n_lines":2},{"id":4188084,"accession":"0001933414-25-000029","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001933414-25-000029","line_url":"/filing/0001933414-25-000029","is_derivative":false,"issuer_cik":"0001672659","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001672659","owner_cik":"0001672659","owner_name":"Rodman David Malcom","owner_display_name":"Rodman David Malcom","owner_url":"/insider/0001672659","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55771.0,"shares_display":"55,771","price_per_share":15.761031362177476,"price_display":"15.76","price_state":"stated","total_value":879008.4801,"total_display":"879,008.48","total_whole":"879,008","shares_owned_after":141901.0,"shares_owned_after_display":"141,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-01","filed_date":"2025-04-03","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":"2025-04-01|4188077","ledger_fault":false,"count":{"value":60,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":60,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":60},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001933414","name":"Mineralys Therapeutics, Inc.","url":"/issuer/0001933414","role":"Officer (Chief Medical Officer)","n_filings":34,"first_seen":"2023-08-11","last_seen":"2026-08-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001626199","name":"Nivalis Therapeutics, Inc.","url":"/issuer/0001626199","role":"Officer (Exec Vice President and CMO)","n_filings":3,"first_seen":"2016-07-06","last_seen":"2017-01-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001672659","retrieved_at":"2026-08-25T08:10:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}